Should aspirin be discontinued before coronary artery bypass surgery?

Circulation

Volumn 112, Issue 7, 2005, Pages

  Sun, Jack C J ^a   Crowther, Mark A ^a   Warkentin, Theodore E ^a   Lamy, Andre ^a   Teoh, Kevin H T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

AGED; ANGINA PECTORIS; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION; HEART DISEASE; HUMAN; MALE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

AGED; ANGINA PECTORIS; ASPIRIN; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; CORONARY DISEASE; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FIBRINOLYTIC AGENTS; HEART DISEASES; HUMANS; MALE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 33644839410     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/circulationaha.105.546697     Document Type: Article

References (0)